Headline
The latest stories from AHA Today.
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.
The agency is investigating 109 potential hepatitis cases of unknown cause in U.S. children since last October, including five deaths.
The guidance is intended to help state policymakers identify and address related issues during and after the public health emergency.
The first edition uses temperature projections to highlight counties at higher risk from extreme heat.
Hospital employment remains over 90,000 below its March 2020 peak, but has grown in 16 of the past 25 months for a slow but steady job recovery.
CDC is investigating 109 potential hepatitis cases of unknown cause in U.S. children since last October; over 90% of the patients were hospitalized.
Based on an updated analysis, FDA said the risk of thrombosis with thrombocytopenia syndrome warrants limiting the vaccine to certain adults.
HRSA will launch May 8 a toll-free hotline for expecting and new mothers experiencing mental health challenges.
Tennessee and South Carolina extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and CHIP enrollees under the American Rescue Plan Act.
AHA today launched a new suite of resources for rural health care leaders, including an on-demand webinar and playbook.